Use of aerosols for bronchial provocation testing in the laboratory: Where we have been and where we are going

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 15, Issue 3, 2002, Pages 313-324

  Anderson, S D ^a   Brannan, J D ^a   Chan, H K ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asthma; Bronchial provocation; Mannitol powder; Osmotic aerosols

Indexed keywords

ADENOSINE PHOSPHATE; HISTAMINE; MANNITOL; SODIUM CHLORIDE; STEROID;

AEROSOL; ASTHMA; AUSTRALIA; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; DISEASE SEVERITY; EXERCISE INDUCED ASTHMA; HUMAN; INFLAMMATION; INHALATION TEST; MAST CELL; POWDER; PROVOCATION TEST;

EID: 0036365481     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/089426802760292663     Document Type: Conference Paper

References (99)

1. The action of histamine on the respiratory tract in normal and asthmatic subjects
2. Air circulent et air captif dans l'exploration de la fonction ventilatrice pulmonaire
3. Standardisation of bronchial inhalation procedures
4. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness
5. Bronchial reactivity to inhaled histamine: A method and clinical survey
6. Rapid method for measurement of bronchial responsiveness
7. Airway responsiveness: Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
8. Guidelines for methacholine and exercise challenge testing - 1999
9. Bronchial reactivity. Its measurement and clinical significance
10. Bronchial responsiveness to histamine: Relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre
11. Relationship between bronchial reactivity, airway caliber and severity of asthma
12. Response of normal infants to inhaled histamine
13. Inhaled corticosteroids reduce the severity of bronchial responsiveness in asthma but oral theophylline does not
14. Airway responsiveness in asthma: Bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide
15. Optimal asthma control, starting with high doses of inhaled budesonide
16. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population
17. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma
18. Differences in airway responsiveness between children and adults living in the same environment: An epidemiological study in two regions of New South Wales
19. Lung function growth and its relation to airway hyperresponsiveness and recent wheeze. Results from a longitudinal population study
20. Analysis of bronchial reactivity in epidemiological studies
21. Seasonal variation in non-specific bronchial reactivity: A study of wheat workers with a history of wheat associated asthma
22. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects
23. 4, and histamine in normal human subjects
24. Testing airway hyperresponsiveness using inhaled methacholine or histamine
25. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children
26. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms
27. Change in bronchial responsiveness to inhaled histamine over four years in middle aged male smokers and ex-smokers
28. Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease
29. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
30. An exercise challenge for epidemiological studies of childhood asthma: Validity and repeatability
31. Exercise-induced airflow obstruction in a healthy military population
32. Inhaled mannitol: A screening test to identify potential exercise-induced bronchoconstriction in elite athletes
33. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction
34. Exercise-induced asthma: Is it the right diagnosis in elite athletes?
35. 20 methacholine
36. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma
37. Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine
38. Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5′-monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze
39. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5′-monophosphate in asthmatic patients
40. How best to measure airway responsiveness
41. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects
42. Acute antiinflammatory effects of inhaled budesonide in asthma: A randomized controlled trial
43. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma
44. Indirect bronchial hyperresponsiveness in asthma: Mechanisms, pharmacology and implications for clinical research
45. The effect of inhaled adenosine 5′-monophosphate (AMP) on airway calibre in normal and asthmatic subjects
46. Inhaled furosemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction
47. Comparison of bronchial responses to ultrasonically nebulized distilled water, exercise, and methacholine in asthma
48. Inhalation provocation tests using nonisotonic aerosols
49. Evaluation of ultrasonically nebulized solutions as a provocation in patients with asthma
50. Inhaled steroids modify bronchial responses to hyperosmolar saline
51. Nedocromil sodium inhibits the airway response to hyperosmolar challenge in patients with asthma
52. A new method for bronchial provocation testing in asthmatic subjects using dry powder of mannitol
53. Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects
54. Inhaled mannitol identifies methacholine-responsive children with active asthma
55. Effect of inhaled preservatives on asthmatic subjects. 1. Sodium metabisulfite
56. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects
57. Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices
58. Provocation by eucapnic voluntary hyperpnoea to identify exercise-induced bronchoconstriction
59. Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma
60. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5′-monophosphate, and exercise in asthmatic children
61. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma
62. Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol
63. Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking
64. The use of non-isotonic aerosols for evaluating bronchial hyperresponsiveness
65. Non-specific bronchoreactivity obtained with an ultrasonic aerosol of distilled water
66. Inhaled furosemide is effective in preventing ultrasonically nebulized 5.8% NaCl bronchoconstriction
67. Inhaled transmembrane ion transport modulators and nonsteroidal anti-inflammatory drugs in asthma
68. Bronchial responsiveness to isotonic fog in occupation asthma due to toluene diiocyanate
69. The use of aerosols of hypertonic saline and distilled water (fog) for the patient with asthma
70. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline
71. A comparison between the airway response to isocapnic hyperventilation and hypertonic saline in subjects with asthma
72. Inhalational challenge using hypertonic saline in asthmatic subjects: A comparison with responses to hyperpnoea, methacholine, and water
73. A comparison of the refactory periods induced by hypertonic airway challenge and exercise in bronchial asthma
74. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist
75. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5 percent saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma
76. The protective effect of nedocromil sodium and other drugs on airway narrowing provoked by hyperosmolar stimuli: A role for the airway epithelium
77. Lung function and bronchial provocation tests for intending divers with a history of asthma
78. Hypertonic saline challenge in an epidemiological survey of asthma in children
79. Prevalence of bronchial hyperresponsiveness to 4.5% saline and its relation to asthma and allergy symptoms in Austrian children
80. Hypertonic saline challenge in an adult epidemiological field survey
81. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood
82. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol
83. Inhalation of mannitol, used as a model for exercise-induced bronchoconstriction (EIB), causes release of leukotrienes and a mast cell marker in asthmatic subjects
84. Novel bronchial provocation tests using dry powders of sodium chloride and mannitol
85. Repeatability of bronchial responsiveness to mannitol dry powder in children with asthma
86. Inhaled mannitol does not cause bronchoconstriction in non asthmatic healthy persons
87. Leukotriene antagonist montelukast sodium reduces time of recovery following challenge with inhaled mannitol without altering sensitivity
88. Nedocromil sodium in the treatment of exercise-induced asthma: A meta-analysis
89. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma
90. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids
91. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
92. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells
93. A comparison of the osmotic activation of basophils and human lung mast cells
94. Selective response of human airway epithelia to luminal but not serosol solution hypertonicity
95. Involvement of calcium and cytoskeleton in gallbladder epithelial cell volume regulation
96. 2+ and protein kinase C signaling for histamine and sulfidoleukotrienes released from human cultured mast cells
97. Activation of ion transport systems during cell volume regulation
98. Biosynthesis of PGD2 in human cells other than mast cells
99. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist